ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 88 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,972,599 | +111.5% | 877,140 | +105.1% | 0.06% | +93.1% |
Q2 2023 | $8,495,836 | +14.7% | 427,571 | -1.2% | 0.03% | +11.5% |
Q1 2023 | $7,410,232 | +37565.1% | 432,588 | -57.0% | 0.03% | -63.4% |
Q4 2022 | $19,674 | -99.9% | 1,005,322 | -27.4% | 0.07% | -16.5% |
Q3 2022 | $22,104,000 | -5.2% | 1,384,934 | -18.2% | 0.08% | -1.2% |
Q2 2022 | $23,306,000 | +11.3% | 1,693,762 | +28.3% | 0.09% | +48.3% |
Q1 2022 | $20,944,000 | +78.7% | 1,320,561 | +145.9% | 0.06% | +70.6% |
Q4 2021 | $11,721,000 | +1236.5% | 536,940 | +1729.3% | 0.03% | +1033.3% |
Q3 2021 | $877,000 | -44.6% | 29,352 | -17.8% | 0.00% | -40.0% |
Q2 2021 | $1,582,000 | -0.6% | 35,711 | -0.4% | 0.01% | -16.7% |
Q1 2021 | $1,592,000 | -34.5% | 35,872 | -19.0% | 0.01% | -45.5% |
Q4 2020 | $2,429,000 | -69.2% | 44,300 | -87.1% | 0.01% | -75.0% |
Q3 2020 | $7,881,000 | -23.5% | 344,729 | -30.0% | 0.04% | -33.3% |
Q2 2020 | $10,305,000 | +198.3% | 492,366 | +113.8% | 0.07% | +153.8% |
Q2 2019 | $3,455,000 | +230.6% | 230,342 | +286.7% | 0.03% | +160.0% |
Q1 2019 | $1,045,000 | +58.1% | 59,567 | +33.5% | 0.01% | +42.9% |
Q4 2018 | $661,000 | – | 44,606 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |